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ter lesions (WML), cerebral atrophy and medial temporal 
lobe atrophy were rated by a standardized visual rating scale. 
Lacunar infarcts were defined as focal hypo-intensities on 
fluid-attenuated inversion recovery sequences with a hyper-
intense rim around it.  Results: WML occurred more fre-
quently in diabetic patients with hypertension as well as 
without hypertension. Significantly more deep WML were 
found in DM patients with and without hypertension when 
compared to control subjects, whereas no difference was 
found in the occurrence of periventricular hyperintensities. 
In all 3 groups, lacunar infarcts occurred sporadically. A trend 
towards higher atrophy scores was seen in patients with DM 
compared to control subjects.  Conclusions: The data of this 
cross-sectional study suggest that type 2 DM is an indepen-
dent risk factor for deep WML in the independently living 
elderly patients.  Copyright © 2007 S. Karger AG, Basel 
 Introduction 
 Diabetes mellitus (DM) has been associated with cog-
nitive impairment and dementia, particularly in the el-
derly  [1] . The exact cerebral mechanisms underlying 
these cognitive deficits remain unclear but brain atrophy 
and vascular changes have both been assumed. Although 
a significant relation between DM and cortical or subcor-
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 Abstract 
 Background and Purpose: Diabetes mellitus (DM) type 2 
has been associated with poor cognitive performance and 
dementia, particularly in elderly patients. The exact mecha-
nisms underlying the cognitive dysfunction in DM remain 
unclear. Imaging studies of the brain could be helpful to give 
more insight into possible structural brain lesions underly-
ing these cognitive dysfunctions. Therefore, we performed 
a study in independently living patients with DM type 2 in 
order to investigate the association between DM and brain 
imaging abnormalities.  Methods: The study population 
consisted of 45 patients with DM type 2 without hyperten-
sion (mean age 73.4  8 5.1 years, mean duration 16.5  8 11.5 
years), 45 patients with DM type 2 and hypertension (mean 
age 73.5  8 6.1 years, mean duration 11.9  8 9.2 years) and 44 
control subjects (mean age 73.1  8 5.4 years). All patients and 
control subjects underwent an MRI of the brain. White mat-
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 The results were published at a poster session during the 2nd con-
gress of the VASCOG Society, Florence, 2005. The data have not been 
published or submitted to a journal in this form. 
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tical atrophy has been found in several studies, the results 
with regard to the relation of DM and white matter le-
sions (WML) or lacunar infarcts are conflicting  [2–10] . 
Reasons for these inconsistencies are methodological 
problems, like the number of patients studied, the use of 
insensitive rating scales to assess WML and patient selec-
tion. Moreover, most studies were not specifically de-
signed to assess the effects of DM on structural brain le-
sions but were performed in a group of selected patients 
who already suffered from a stroke  [2, 5, 7, 9] . In addition, 
a distinction into type 1 or type 2 DM was usually not 
made in most studies, while they may have different ef-
fects on the brain. Often type 2 DM typically develops in 
the context of a cluster of vascular and metabolic risk fac-
tors, like hypertension, dyslipidaemia and obesity, also 
called the ‘metabolic syndrome’, which each could lead to 
brain damage itself. Indeed, hypertension is the most 
consistent risk factor associated with WML and has been 
reported to increase the risk for WML approximately 
twofold  [11–13] . More detailed insight into structural 
brain abnormalities that may underlie changes in cogni-
tion in diabetic patients could provide important clues 
into the pathogenesis.
 Therefore, we performed a study in a well-defined 
group of independently living elderly patients with type 
2 DM to investigate the association between type 2 DM, 
WML, lacunar infarcts and brain atrophy. Furthermore 
we compared diabetic patients with and without hyper-
tension to assess if concomitant hypertension could be 
defined as a relevant disease variable in DM patients or if 
DM is an independent risk factor.
 Methods 
 The study population consisted of 45 type 2 DM patients with 
hypertension, 45 type 2 DM patients without hypertension and 
44 control subjects without DM and without hypertension. DM 
patients were recruited from the department of internal medicine 
in the Sint Lucas Andreas Hospital during a time period from 
2001 to 2004. The diagnosis of DM was made according to the 
WHO criteria  [14] . 
 Control subjects were age-matched healthy partners or neuro-
logical out-patients, visiting the hospital for low back pain or a 
peripheral nerve problem. Control subjects were without any car-
diovascular or metabolic disorder. All were recruited by the same 
neurologist (B.v.H.). Exclusion criteria for patients as well as con-
trol subjects were cerebrovascular accidents, intracranial tu-
mours, neurodegenerative diseases and alcohol intake of  1 3 
units/day. 
 Information on current health status, medical history, drug 
prescriptions, smoking behaviour and level of education was ob-
tained by means of an interview. Educational attainment was rat-
ed on an ordinal scale ranging from 1 (incomplete primary) to 7 
(university). Total serum cholesterol, high-density lipoprotein, 
glucose and glycosylated haemoglobin (glyco-Hb) were deter-
mined. Blood pressure was measured in the upright sitting posi-
tion using an aneroid sphygmomanometer. Measurements were 
done on 2 different occasions with a minimal interval of 4 weeks. 
The diagnosis of hypertension was based on history or if the mean 
of at least 2 measurements was systolic  6 160 mm Hg or diastolic 
 6 95 mm Hg.
 Brain MRI were obtained with a 1.5-tesla scan (General Elec-
tric, Milwaukee, Wisc., USA). Whole-brain axial and coronal flu-
id-attenuated inversion recovery (FLAIR) and axial T 2 -weighted 
images were acquired to allow detailed visualization of WML and 
lacunar infarcts. Coronal FLAIR images and sagittal T 1 -weighted 
images were acquired to allow measurement of medial temporal 
lobe atrophy (MTA) and whole-brain volume. The MRI scans 
were analysed by an experienced rater (P.S.) who was blinded to 
all clinical information. The Scheltens scale was used to assess 
periventricular hyperintensities (PVH), white matter hyperin-
tensities (WMH), basal ganglia hyperintensities and infratento-
rial foci of hyperintensities  [15] . The PVH were examined in 3 
regions, frontal and occipital gaps and periventricular bands, 
which were rated as follows: none (score 0); 5 mm or less (score 1); 
6 mm or greater (score 2). The WMH were examined in 4 regions 
of the brain, the temporal, frontal, parietal and occipital lobes, 
which were rated as follows: none (score 0); 3 mm or less and 5 or 
fewer lesions (score 1); 3 mm or less and 6 or more lesions (score 
2); 4–10 mm and 5 or fewer lesions (score 3); 4–10 mm and 6 or 
more lesions (score 4); 11 mm or greater and 1 or more lesions 
(score 5); and large confluent lesions (score 6). The basal ganglia 
hyperintensities were examined in 5 regions of the basal ganglia, 
the head of the caudate, putamen, globus pallidus, thalamus, and 
internal and external capsule (scores similar to the WMH). The 
infratentorial foci of hyperintensities were examined in 4 regions 
of the infratentorial structures, the cerebellum, mesencephalon, 
pons and medulla with scores similar to the WMH. Total scores 
and subscores were used for analysis, whereby a total of deep 
WML (DWML) was derived by summing WMH and basal gan-
glia hyperintensity scores. The presence of PVH and DWML is 
illustrated in  figure 1 .
 Cerebral atrophy and MTA were measured by a 5-point visual 
rating scale  [16, 17] . Mean scores of left and right MTA were used 
for analysis. Lacunar infarcts were defined as focal hypo-intensi-
ties corresponding on FLAIR sequences with a hyperintense rim 
around it ( fig. 1 d). Distinction from dilated perivascular spaces 
was made on the basis of location, size and shape of the hypo-in-
tense abnormalities. The number of patients with lacunar infarcts 
(n  6 1) was used for analysis. 
 Statistical Analysis 
 Data were analysed with the statistical package SPSS for
Windows (release 12.0, SPSS, Chicago, Ill., USA). Baseline differ-
ences between groups were assessed using analysis of variance
(ANOVA), Kruskal-Wallis test and    2  tests as appropriate. Non-
parametric tests were used for comparison of WML, lacunar in-
farcts, MTA and cerebral atrophy. Correlations were computed 
with Spearman’s correlation coefficient. All statistical tests were 
two-tailed, and significance was accepted at a level of p  ! 0.05.
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 Results 
 The groups were comparable with regard to sociode-
mographic factors and lipoprotein levels ( table 1 ). The 
mean systolic pressure was significantly higher in the 
DM group with hypertension. The mean duration of DM 
was significantly longer in patients without hyperten-
sion. MRI data were inconclusive in 2 patients due to 
claustrophobia. The total WML score was statistically 
significantly higher in DM patients compared to control 
subjects (p = 0.02;  table 2 ). DWML occurred more fre-
quently in patients with DM (p = 0.007), whereas the oc-
currence of PVH did not (p = 0.3). The total amount of 
WML and DWML showed higher scores in DM patients 
with hypertension compared to those without, but sig-
nificance was not reached (p = 0.74 and p = 0.91, respec-
tively). The prevalence of lacunar infarcts in all 3 groups 
was low without significant differences (p = 0.68;  table 2 ). 
Although atrophy scores tended to be higher in the DM 
group, a statistically significant association was not found 
for MTA (p = 0.48) or global atrophy (p = 0.25;  table 2 ). 
A significant positive correlation was found between the 
value of glyco-Hb and total WML score (r = 0.25, p = 0.02) 
as well as DWML score (r = 0.25, p = 0.02). The correla-
tion of glyco-Hb with PVH was not significant. The du-
ration of DM correlated significantly with PVH (r = 0.24, 
p = 0.03), DWML (r = 0.28, p = 0.01) and total WML score 
(r = 0.29, p = 0.008).
 Discussion 
 We found more DWML in a group of independently 
living elderly patients with type 2 DM compared to 
healthy control subjects. A relation between DM and la-
cunar infarcts and DM and atrophy was not found. No 
significant differences were found between the DM 
groups with and without hypertension. The significantly 
positive correlation between the duration of DM and 
WML may explain the non-significant differences in 
findings between diabetic patients with and without hy-
pertension. To strengthen the association between type 2 
DM and DWML, we found significantly positive correla-
 Fig. 1. Examples of PVH (open arrows), DWML (black arrows;  a–c ) and lacunar infarcts ( d ) on axial FLAIR 
sequences.  







n 45 45 44
Age, years 73.5 (6.1) 73.4 (5.1) 73.1 (5.4)
Sex (M/F) 19/26 21/24 21/23
Duration of DM, years 11.9 (9.2)b 16.5 (11.5) –
Median education, years 4.0 4.0 4.5
Smoking behaviour (yes/no) 3/42 7/38 6/38
Atrial fibrillation 4 4 0
RR systolic 155 (19)a, b 136 (12) 144 (14.9)
RR diastolic 80 (10)b 75 (7)a 83 (8)
Cholesterol/HDL 4.8 (1.3) 4.2 (1.4) 4.5 (1.4)
Glyco-Hb 7.7 (1.0)a 7.8 (1.0)a 5.8 (1.1)
OAD/insulin 9/36 14/31 –
Data are expressed as means, with SD in parentheses; analyses 
were done with ANOVA with post hoc Bonferroni tests, 2 tests 
or Kruskal-Wallis tests when appropriate.
HDL = High-density lipoprotein; OAD = oral antidiabetics.
a p < 0.05 compared to the control group
b p < 0.05 compared to the other patient group.
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tions between the severity of DWML and the value of 
glyco-Hb and the duration of DM, respectively.
 A number of studies addressing the association be-
tween DM and WML have been published previously 
with inconsistent results. We have chosen a case-control 
study design consisting of independently living elderly 
out-patients with type 2 DM, which may have implica-
tions for these specific patients. Our results with regard 
to DWML are in line with a recently published study in a 
group of patients with type 2 DM recruited from general 
practitioners, but in contrast to our study differences in 
atrophy scores were also significant  [18] . Two other rela-
tively small case-control studies have shown conflicting 
results with regard to DM and WML, but only patients 
with type 1 DM were included  [19, 20] . Two population-
based studies demonstrated a relation of DM with cere-
bral atrophy, whereas an association with WML was not 
found  [3, 6] . Most other studies used dichotomous or or-
dinal rating scales, which may be not sensitive enough in 
the discrimination between various degrees of WML  [2, 
7–10] . This might be important, because the consistently 
reported modest cognitive deficits in DM patients do not 
suggest severe lesions and the used scales may therefore 
underestimate WML in DM patients  [1] . In contrast, the 
Scheltens scale, which was used in the present study, is 
able to detect small amounts of WML  [15] . Furthermore, 
other studies were not designed to specifically assess the 
effects of DM on neuro-imaging modalities but assessed 
the effect of DM in selected patients with stroke or other 
cardiovascular risk factors  [2, 5, 7, 9] . The results of these 
studies have low external validity and do not allow to 
 generalize to the DM population visiting an out-patient 
clinic.
 The difference between the association of DM with 
DWML versus PVH supports the hypothesis that DWML 
and PVH are pathologically different. It has already been 
suggested that PVH is more associated with atrophic pro-
cesses involving ventricular enlargement whereas DWML 
is associated with cerebrovascular risk factors  [21, 22] .
 The results of the present study may be important to 
provide clues for the pathogenesis of cognitive impair-
ment in DM patients. To our knowledge only one study 
analysed cognitive function and brain imaging within a 
type 2 DM population and found some associations be-
tween cognitive function and brain MRI abnormalities 
 [18] .
 Among the limitations of the present study is firstly 
the use of a visual rating scale for assessing atrophy. Al-
though visual rating of MTA is a clinically useful method 
for differentiating Alzheimer’s disease from controls and 
is quicker and more accurate than volumetry  [23] , volu-
metric scales may be more sensitive in our study popula-
tion without clinically diagnosed dementia. This may ex-
plain the non-significant trend towards higher atrophy 
scores in DM patients compared to controls. Secondly, 
actual volumetric assessments may be more sensitive to 
assess WML, but in fact a significant agreement of the 
Scheltens scale with quantitative volumetric measure-
ments has been shown, so results are not expected to dif-
fer much when volumetry had been used  [24] . Finally, the 
DM Control
subjects
(n = 44)with hyper-tension (n = 44)
without hyper-
tension (n = 44)
Total WML score 5.9 (5.6)* 5.4 (3.7)* 3.3 (2.4)
PVH 2.5 (1.5) 2.8 (1.6) 2.2 (1.4)
DWML 3.3 (4.4)* 2.6 (2.5)* 1.2 (1.4)
IFH 0.1 (0.4) 0.0 (0.1) 0 (0)
Lacunar infarcts (patients) 5 3 3
MTA 0.38 (0.56) 0.44 (0.70) 0.28 (0.55)
Global atrophy 1.0 (0.5) 1.2 (0.7) 0.9 (0.6)
IFH = Infratentorial foci of hyperintensities.
Values of the WML total score, subscores, medial temporal lobe atrophy and global 
atrophy scores are expressed as means, with SD in parentheses. The lacunar infarcts are 
expressed as the number of patients with lacunar infarcts; Kruskal-Wallis tests were per-
formed for the analysis of WML and atrophy, 2 tests for the differences of lacunar in-
farcts.
* p < 0.05 compared to the control group.
Table 2. Prevalence of WML, lacunar 
 infarcts and atrophy between the 
 different groups
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prevalence of lacunar infarcts was low and may therefore 
explain the non-significant differences in the DM pa-
tients with hypertension compared to those without as 
well as the control subjects due to lack of statistical 
 power.
 In conclusion, the data of this cross-sectional study 
show that type 2 DM is an independent risk factor for 
DWML in the independently living elderly patients. The 
significantly positive correlation between the value of 
glyco-Hb and the severity of WML may have important 
therapeutic implications suggesting that better metabolic 
control in the elderly patients with type 2 DM could pre-
vent worsening of WML. Further studies are needed to 
investigate the relations between MRI measures and cog-
nitive decline in DM patients.
 Acknowledgement 
 The study was supported by a grant from the Roomsch Catholyk 
Oude-Armenkantoor of Amsterdam and the Stichting Alzheimer 
and Neuropsychiatrie Foundation Amsterdam. We are grateful to 
Dr. W.M. van der Flier for help with statistical analyses.
 
 References 
 1 Stewart R, Liolitsa D: Type 2 diabetes melli-
tus, cognitive impairment and dementia. Di-
abet Med 1999;  16:  93–112. 
 2 Streifler JY, Eliasziw M, Benavente OR, et al: 
Development and progression of leukoaraio-
sis in patients with brain ischemia and ca-
rotid artery disease. Stroke 2003;  34:  1913–
1916. 
 3 Schmidt R, Launer LJ, Nilsson LG, et al: 
Magnetic resonance imaging of the brain in 
diabetes: the Cardiovascular Determinants 
of Dementia (CASCADE) Study. Diabetes 
2004;  53:  687–692. 
 4 Vermeer SE, den Heijer T, Koudstaal PJ, et al: 
Incidence and risk factors of silent brain in-
farcts in the population-based Rotterdam 
Scan Study. Stroke 2003;  34:  392–396. 
 5 Giele JL, Witkamp TD, Mali WP, van der 
Graaf Y: Silent brain infarcts in patients with 
manifest vascular disease. Stroke 2004;  35: 
 742–746. 
 6 den Heijer T, Vermeer SE, van Dijk EJ, et al: 
Type 2 diabetes and atrophy of medial tem-
poral lobe structures on brain MRI. Diabe-
tologia 2003;  46:  1604–1610. 
 7 Manolio TA, Kronmal RA, Burke GL, et al: 
Magnetic resonance abnormalities and car-
diovascular disease in older adults. The Car-
diovascular Health Study. Stroke 1994;  25: 
 318–327. 
 8 Longstreth WT Jr, Manolio TA, Arnold A, et 
al: Clinical correlates of white matter find-
ings on cranial magnetic resonance imaging 
of 3,301 elderly people. The Cardiovascular 
Health Study. Stroke 1996;  27:  1274–1282. 
 9 Coskun O, Yildiz H, Emre U, et al: Leuko-
araiosis in stroke patients. Int J Neurosci 
2003;  113:  915–922. 
 10 Longstreth WT Jr, Arnold AM, Manolio TA, 
et al: Clinical correlates of ventricular and 
sulcal size on cranial magnetic resonance 
imaging of 3,301 elderly people. The Cardio-
vascular Health Study. Collaborative Re-
search Group. Neuroepidemiology 2000;  19: 
 30–42. 
 11 Launer LJ: Epidemiology of white matter le-
sions. Top Magn Reson Imaging 2004;  15: 
 365–367. 
 12 van Dijk EJ, Breteler MM, Schmidt R, et al: 
The association between blood pressure, 
 hypertension, and cerebral white matter le-
sions: cardiovascular determinants of de-
mentia study. Hypertension 2004;  44:  625–
630. 
 13 Skoog I: A review on blood pressure and 
ischaemic white matter lesions. Dement 
Geriatr Cogn Disord 1998;  9(suppl 1):13–19. 
 14 World Health Organization: Classification 
of diabetes mellitus and its complications. 
Geneva, Department of Noncommunicable 
Disease Surveillance, 1999, pp 1–59. 
 15 Scheltens P, Barkhof F, Leys D, et al: A semi-
quantitative rating scale for the assessment 
of signal hyperintensities on magnetic reso-
nance imaging. J Neurol Sci 1993;  114:  7–12. 
 16 Scheltens P, Leys D, Barkhof F, et al: Atrophy 
of medial temporal lobes on MRI in ‘proba-
ble’ Alzheimer’s disease and normal ageing: 
diagnostic value and neuropsychological 
correlates. J Neurol Neurosurg Psychiatry 
1992;  55:  967–972. 
 17 Scheltens P, Pasquier F, Weerts JG, Barkhof 
F, Leys D: Qualitative assessment of cerebral 
atrophy on MRI: inter- and intra-observer 
reproducibility in dementia and normal ag-
ing. Eur Neurol 1997;  37:  95–99. 
 18 Manschot SM, Brands AM, van der Grond J, 
et al: Brain magnetic resonance imaging cor-
relates of impaired cognition in patients with 
type 2 diabetes. Diabetes 2006;  55:  1106–
1113. 
 19 Yousem DM, Tasman WS, Grossman RI: 
Proliferative retinopathy: absence of white 
matter lesions at MR imaging. Radiology 
1991;  179:  229–230. 
 20 Dejgaard A, Gade A, Larsson H, et al: Evi-
dence for diabetic encephalopathy. Diabet 
Med 1991;  8:  162–167. 
 21 Scheltens P, Barkhof F, Leys D, et al: Histo-
pathologic correlates of white matter chang-
es on MRI in Alzheimer’s disease and nor-
mal aging. Neurology 1995;  45:  883–888. 
 22 Barber R, Gholkar A, Scheltens P, et al: MRI 
volumetric correlates of white matter lesions 
in dementia with Lewy bodies and Alzhei-
mer’s disease. Int J Geriatr Psychiatry 2000; 
 15:  911–916. 
 23 Wahlund LO, Julin P, Johansson SE, Schel-
tens P: Visual rating and volumetry of the 
medial temporal lobe on magnetic resonance 
imaging in dementia: a comparative study. J 
Neurol Neurosurg Psychiatry 2000;  69:  630–
635. 
 24 Kapeller P, Barber R, Vermeulen RJ, et al: Vi-
sual rating of age-related white matter 
changes on magnetic resonance imaging: 
scale comparison, interrater agreement, and 
correlations with quantitative measure-
ments. Stroke 2003;  34:  441–445. 
 
